Last edition
News about
FDA Approves RYBREVANT Plus Chemotherapy for NSCLC with EGFR Exon 20 Insertion Mutations
This approval, following a priority review, builds upon the accelerated approval of RYBREVANT® in May 2021, based on the Phase 3 PAPILLON study results.
Dr. Rahul Rathod Named Global Principal Investigator for Mezzion Pharmaceuticals' FUEL-2 Trial
Dr. Rathod, a distinguished pediatric cardiology specialist with over two decades of expertise at Boston Children's Hospital, brings extensive experience to this crucial role.
Ginkgo Bioworks Acquires Reverie Labs to Strengthen AI-Driven Drug Discovery
This strategic move aims to enhance Ginkgo's capabilities in AI-driven drug discovery and advance its efforts in developing next-generation biological foundation models.
AbbVie and OSE Immunotherapeutics Forge Partnership to Advance OSE-230 Monoclonal Antibody
OSE-230 represents a pioneering approach as a first-in-class monoclonal antibody designed to activate ChemR23, a G-Protein Coupled Receptor (GPCR) target.
Gericke Celebrates 130 Years of Bulk Handling Solutions
For over a century, the Swiss family-owned company has been a leader in the manufacture of systems and machines for processing bulk solids. What once began in a modest location in Zurich has developed into a global group of companies with 350 employees.
Lindstrom Continues South India Investment, Opens new Cleanroom Facility in Hyderabad
This is reminiscent of the company’s high growth in India which has further bolstered its investments for expanding its operation.
API Launches Website 'Cough Xpert' at its 79th Annual Conference 'APICON' in New Delhi
The user-friendly website, Cough Xpert is designed to assist Healthcare Professionals in determining cough symptom differentials based on various parameters such as the type of cough, mucus, triggering factors, and accompanying symptoms.
TechInvention Lifecare Pvt. Ltd. is proud to announce the ground breaking of its Global Collaborative Centre for Medical Countermeasures (GCMC) with an investment of approx. USD 15 million. The centre is strategically located close to the upcoming international a
LTS Launches Sorrel Wearable Drug Delivery Platform with Coherus BioSciences
The platform debuts alongside Coherus' UDENYCA® on-body injector (OBI), a solution for administering pegfilgrastim-cbqv, a biosimilar pegfilgrastim utilized post-chemotherapy to mitigate infection risks.
Telix Pharmaceuticals Acquires IsoTherapeutics Group
One of the key benefits of this acquisition is the enhancement of Telix's manufacturing capabilities, particularly in the United States.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy